CIK 0001790340
- Emerging growth company
Immuneering Corp
Sign in to watch- Ticker
- IMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-500-8080
- Business address
- 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
- 4 Open-market buy Director bought 21,645 shares at $4.67 ($101,041)
- 4 Open-market buy CHIEF SCIENTIFIC OFFICER bought 2,298 shares at $4.57 ($10,502)
- 4 Open-market buy CHIEF PEOPLE OFFICER bought 2,626 shares at $4.15 ($10,906)
- 4 Open-market buy Director bought 20,000 shares at $4.35 ($86,904)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 7,500 shares at $6.67 ($50,025)
- 4 Open-market buy Chief Accounting Officer bought 300 shares at $6.39 ($1,917)
- 4 Open-market buy CHIEF PEOPLE OFFICER bought 800 shares at $6.38 ($5,103)
- 4 Open-market buy CHIEF LEGAL OFFICER, SECRETARY bought 1,020 shares at $6.83 ($6,966)
- 4 Open-market buy Director bought 7,500 shares at $7.03 ($52,730)
- 4 Open-market buy Director bought 5,000 shares at $7.18 ($35,900)
- 4 Grant or award CHIEF PEOPLE OFFICER acquired 11,815 shares (grant or award)
- 4 Grant or award Chief Accounting Officer acquired 14,497 shares (grant or award)
- 4 Grant or award CHIEF SCIENTIFIC OFFICER acquired 14,880 shares (grant or award)
- 4 Open-market buy Director bought 5,500 shares at an average $3.61 ($19,863)
- 4 Open-market buy CHIEF PEOPLE OFFICER bought 700 shares at $3.57 ($2,499)
- 4 Open-market buy PRESIDENT AND CEO bought 10,000 shares at an average $3.49 ($34,879)
- 4 Open-market buy Director bought 9,500 shares at $3.66 ($34,788)
- 4 Open-market buy CHIEF SCIENTIFIC OFFICER bought 13,422 shares at an average $2.58 ($34,616)
Page 2 of 9 · 165 filings